3Indexed trials
drug · Product Intelligence
Etoposide
Pipeline Intelligence
Etoposide: 3 indexed trials, 1 sponsors; 0 linked Orange Book patents and 17 FDA-linked events where matched.
1Sponsors
0Orange Book patent links
17FDA-linked events
Development evidence
NCT02964013Merck Sharp & Dohme LLC · parkinsonsPHASE1
NCT03066778Merck Sharp & Dohme LLC · parkinsonsPHASE3
NCT05008224Merck Sharp & Dohme LLC · parkinsonsPHASE2
FDA / patent evidence
Orange Book match found; no listed patent relation was retained for this product match.
Regulatory context
FDA_APPROVALAVOPEF · 2026-06-24
FDA_APPROVALETOPOSIDE · 2017-11-20
FDA_APPROVALETOPOSIDE · 2017-10-31
FDA_APPROVALETOPOSIDE · 2001-09-19
FDA_APPROVALETOPOSIDE · 1998-09-30
FDA_APPROVALETOPOPHOS PRESERVATIVE FREE · 1998-02-27
FDA_APPROVALETOPOSIDE · 1997-07-09
FDA_APPROVALETOPOSIDE · 1996-10-15
FDA_APPROVALETOPOPHOS PRESERVATIVE FREE · 1996-05-17
FDA_APPROVALETOPOSIDE · 1996-03-14
FDA_APPROVALETOPOSIDE · 1996-02-22
FDA_APPROVALETOPOSIDE · 1995-08-30
FDA Orange Book coverage is U.S.-specific and is not a substitute for worldwide patent or regulatory review.